Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-18

FDA Approved: CLOMID — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CLOMID (clomiphene citrate) from Cosette Pharmaceuticals, Inc., clearing a generic version under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clomid (clomiphene citrate)

Snippet

SUPPL AP for CLOMID (CLOMIPHENE CITRATE)